We’re pleased to announce that Prof. Magdalena Król, CSO of Cellis, will be presenting in the Emerging Biotech Company category at Swiss Biotech Day 2025—a leading global platform for innovation and collaboration in life sciences.
Join us on:
May 6 | 15:45–16:00 | Room: Singapore
Presentation Title: Revolutionizing Solid Tumors Treatment with Macrophage Drug Conjugates
Magdalena will introduce our proprietary Macrophage Drug Conjugates (MDC) and the breakthrough TRAIN mechanism—a Trojan Horse–like strategy that enables potent, sustained immune activation and tumor regression with minimal drug exposure.
We look forward to connecting with fellow researchers, partners, and biotech leaders in Basel.
#SwissBiotechDay #Immunotherapy #Macrophages
